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Ex-vivo recellularisation 
and stem cell differentiation 
of a decellularised rat dental pulp 
matrix
Manal Matoug-Elwerfelli1,2, Hani Nazzal3,4, El Mostafa Raif1, Stacy-Paul Wilshaw5,6, 
Filomena Esteves7 & Monty Duggal3,8*
Implementing the principles of tissue engineering within the clinical management of non-vital 
immature permanent teeth is of clinical interest. However, the ideal scaffold remains elusive. The 
aim of this work was to assess the feasibility of decellularising rat dental pulp tissue and evaluate the 
ability of such scaffold to support stem cell repopulation. Rat dental pulps were retrieved and divided 
into control and decellularised groups. The decellularisation protocol incorporated a low detergent 
concentration and hypotonic buffers. After decellularisation, the scaffolds were characterised 
histologically, immunohistochemistry and the residual DNA content quantified. Surface topography 
was also viewed under scanning electron microscopy. Biocompatibility was evaluated using 
cytotoxicity assays utilising L-929 cell line. Decellularised scaffolds were recellularised with human 
dental pulp stem cells up to 14 days in vitro. Cellular viability was assessed using LIVE/DEAD stain 
kit and the recellularised scaffolds were further assessed histologically and immunolabelled using 
makers for odontoblastic differentiation, cytoskeleton components and growth factors. Analysis of 
the decellularised scaffolds revealed an acellular matrix with histological preservation of structural 
components. Decellularised scaffolds were biocompatible and able to support stem cell survival 
following recellularisation. Immunolabelling of the recellularised scaffolds demonstrated positive 
cellular expression against the tested markers in culture. This study has demonstrated the feasibility 
of developing a biocompatible decellularised dental pulp scaffold, which is able to support dental pulp 
stem cell repopulation. Clinically, decellularised pulp tissue could possibly be a suitable scaffold for use 
within regenerative (reparative) endodontic techniques.
Preserving pulp vitality, in pulpally compromised teeth, is the ultimate goal in  dentistry1,2, however; despite our 
best efforts such goal is not always achievable. The management of teeth with necrotic pulps is extremely chal-
lenging especially in immature teeth with compromised crown root ratio, and thin dentinal walls. The use of a 
bioengineered treatment strategy allowing pulpal regeneration and continuation of root development, therefore, 
is highly  advantageous3,4. Consequently, careful consideration and incorporation of bioengineering principles 
(the use of stem cells, scaffold material and morphogenic signals) within such a treatment strategy is essential in 
the clinical application of  regenerative5–7, or more accurately termed  reparative8, endodontics.
Several natural and synthetic scaffold materials have been proposed for regeneration of the pulp dentine 
complex, however, the ideal scaffold is yet to be  identified5,9. A recent review of the literature highlighted a large 
heterogeneity of results on several tested scaffold materials, highlighting the need to develop a new scaffold 
material with close resemblance to the natural pulp  matrix10.
More recently, the use of biological scaffolds derived through tissue decellularisation has been  advocated11,12. 
Ideally, the produced decellularised scaffold should be composed of an acellular extracellular matrix (ECM) with 
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a preserved three-dimensional histological architecture and natural structural  components13. The ECM is a vital 
and dynamic structure composed of tissue specific structural and functional proteins. This complex integration 
between cells and the surrounding microenvironment (ECM proteins) regulates cellular activity and may provide 
a suitable environment for tissue  regeneration14.
Biological scaffolds derived from tissue decellularisation have been assessed for dental applications including 
decellularisation of bovine pulp  tissue15, porcine tooth  buds16,17, swine pulp  tissue18,19, human root  slices20, and 
human pulp  tissue6. While successful biocompatible decellularisation have been shown in human pulp  tissues6, 
further research is required to show the decellularised scaffolds’ ability to support stem cell recellularisation and 
differentiation into odontoblast-like cells.
Decellularised rat tissues, as experimental models, have been reported in the  literature21,22, and can be 
regarded as an alternative research tissue source to human tissues which are becoming increasingly difficult to 
obtain. Of interest, histological characterisation of rat dental pulp tissues has shown similar structural composi-
tion to human pulp  tissues23,24. Therefore the aim of the present work was to illustrate the ability to decellularise 
rat pulp tissues using low concentration detergents and evaluate the ability of such decellularised scaffold to 
support stem cell growth and differentiation.
Materials and methods
Ethical consideration. All experimental protocols and study design was approved by the Research Eth-
ics Committee, University of Leeds, United Kingdom (approval no. 101013/MME/113). The use of human and 
animal tissue in this study followed relevant guidelines and regulations as set by University of Leeds Research 
Ethics Committee.
Tissue procurement. Rat jaws were only collected for this study. Wistar male rats (28 ± 2 days old) were 
humane killed in-advance in the Central Biomedical Services (University of Leeds, Leeds, United Kingdom) as 
per the institutional animal use and care committee at the University of Leeds and according to guidelines laid 
down by the Animals (Scientific Procedures) Act 1986. Dental pulp tissues were aseptically retrieved from the 
rat mandibular incisors and stored in 0.1 M phosphate-buffered saline (PBS, 17-516F, Lonza, Slough, United 
Kingdom; pH 7.4) at − 80 °C for up to 4 weeks. All reagents and solutions were purchased from Sigma-Aldrich 
(Poole, United Kingdom) and cell culture plastics were obtained from Corning, Inc. (Amsterdam, The Nether-
lands) unless stated otherwise.
Decellularisation of dental pulp. Tissue decellularisation was performed as described by Matoug-Elw-
erfelli et al. (2018). Under sterile conditions, pulp tissues were thawed and processed individually in 4 mL solu-
tions and the following protocol was performed. Initially, pulp tissues were incubated in hypotonic Tris-buffer 
(10 mM Tris, T3038, pH 8.0) containing protease inhibitors [(0.1%, w/v ethylenediaminetetraacetic acid; EDTA, 
036980 and (10 KIU/mL aprotinin, A6279)] overnight at 4 °C. Pulp tissues were then subjected to a single cycle 
of a hypotonic buffer containing 0.03% (w/v) sodium dodecyl sulphate (SDS, 71736) and protease inhibitors for 
24 h at room temperature with agitation. Pulp tissues were washed three times in Tris-buffered saline (pH 7.4, 
T5912) with agitation. Following washing, pulp tissues were incubated in 50 U/mL DNase (AMPD1) and 1 U/
mL RNase (R4642) in a buffer [(50 mM Tris-hydrochloric acid (93313), 10 mM magnesium chloride (M1028), 
and 50 µg/mL bovine serum albumin (A7979) pH 7.5] for 3 h at 37 °C with agitation. Pulp tissues were subse-
quently washed in Tris-buffered saline (pH 7.4) with agitation. Incubation in 0.1% (v/v) peracetic acid (77240) 
in PBS for 3 h served as a final disinfection. Finally, tissues were washed three times in Tris-buffered saline (pH 
7.4) for 1.5 h at room temperature with agitation.
Tissue preparation. Samples of control and decellularised rat pulps (n = 4 per group) were fixed in 10% 
(w/v) neutral buffered formalin (BAF-6000-08A, CellPath Ltd, Newtown, United Kingdom) for 24 h. Fixed tis-
sues were embedded in 2% (w/v) agar (A-9915), dehydrated in an automated tissue processor (ASP200, Leica 
Biosystems Newcastle Ltd, Newcastle Upon Tyne, United Kingdom), embedded in paraffin wax and serially sec-
tioned at 5 μm. These sections were then used for the following histology and immunohistochemistry analysis.
Histology analysis. Paraffin embedded tissue sections were dewaxed utilising 4 changes of xylene (X/0250, 
Thermo Fisher Scientific, Loughborough, United Kingdom) for 5 min each and rehydrated using descending eth-
anol series [100, 90 and 75% (v/v) for 2 min each]. Following dewaxing and rehydration, tissue sections of control 
and decellularised pulp tissues were stained using standard histological procedures with haematoxylin and eosin 
(H&E; RRSP60-D, Thermo Fisher Scientific), 4′,6-diamidino-2-phenylindole (DAPI, H-1200, Vector Labora-
tories Ltd, Peterborough, United Kingdom), alcian blue (RRSK400, TCS Biosciences Ltd, Buckingham, United 
Kingdom), and picrosirius red (24901, Polysciences, Inc. Northampton, United Kingdom). Following staining; 
the slides were dehydrated using ascending ethanol series [75% for 5 min and 3 changes of 100% (v/v) for 20 s], 
cleared in four successive changes of xylene for 5 min each and then mounted with synthetic resin media (DPX 
mountant, REA212, Solmedia Ltd, Shrewsbury, United Kingdom). All slides were viewed using either normal 
Köhler illumination, polarised light or under reflected light and a DAPI filter (λex = 365 nm/λem = 445/450 nm) 
with images captured digitally using an AxioCam and AxioVision or Zen software (ZEISS, Cambridge, United 
Kingdom) and qualitatively assessed.
Immunohistochemistry analysis. Following dewaxing and rehydration (as mentioned above), antigen 
retrieval methods were performed using either; (1) Bond enzyme pre-treatment kit (AR9551, Leica Biosys-
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tems Newcastle Ltd.) by incubating slides for 15 min at 37 °C or (2) Heat-induced antigen unmasking solution 
[Tris–EDTA buffer solution (pH 9.0) or citric acid buffer solution (pH 6.0)] (Vector Laboratories Ltd.) in an 
automated pressure cook for 2 min under full pressure as per manufacturer’s instructions. Following antigen 
retrieval, slides were then incubated at room temperature for 1 h with the following primary antibodies; mouse 
monoclonal antibodies against collagen type I (1:100, ab90395, Abcam, Cambridge, United Kingdom), collagen 
type III (1:200, ab6310, Abcam), fibronectin (1:50, ab6328, Abcam,), Alpha-1,3 Galactose (α-gal, 1:200, ALX-
801–090, Enzo Life Sciences, Inc., Lausen, Switzerland), major histocompatibility class II RT1B (1:200, Bio-Rad 
Laboratories Ltd, Hertfordshire, United Kingdom), and rabbit polyclonal laminin antibody (1:400, NB300-144, 
Novus Biologicals, Abingdon, United Kingdom) were used to assess collagen matrix, xenoepitope expression, 
specific cellular and basement proteins components. Secondary antibody staining (immunolabelling) using 
either ImmPRESS Excel peroxidase anti-mouse (MP-7602, Vector Laboratories Ltd.) or horseradish peroxidase 
anti-rabbit polymer (MP-7401, Vector Laboratories Ltd.) were used following manufacturer’s instructions. Tris-
buffered saline (pH 7.4) was used throughout as the diluent and wash buffer. Non-specific background staining 
was prevented by endogenous hydrogen peroxide blocking with Bloxall (SP-6000, Vector Laboratories Ltd.) and 
protein blocking (1/10 casein, Ssp-5020, Vector Laboratories Ltd.). Next, the slides were washed twice with Tris-
buffered saline with 0.1% (v/v) Tween 20 (pH 7.6; T9039) and stained with ImmPACT 3,3′-diaminobenzidine 
(DAB) peroxidase chromogen substrate (SK-4105, Vector Laboratories Ltd.) for 5 min. Omission of the primary 
antibody served as the negative control. Isotype control antibodies [(IgG, IgG1; Abcam), (IgG1 Kappa, IgG2b 
Kappa; Sigma-Aldrich), (IgM; Novus Biologicals), (IgG2a Kappa; Dako, Agilent Technologies Ltd. Cheshire, 
United Kingdom)] were used to verify antibody specificity. Following antibody labeling all sections were coun-
ter stained using Mayer’s hematoxylin, dehydrated, cleared and mounted (as mentioned above). All slides were 
viewed under Köhler illumination with images captured digitally using an AxioCam and AxioVision software 
(ZEISS) and qualitatively assessed.
DNA quantification assay. Total DNA was extracted using a DNA isolation kit for tissues (69504, QIA-
GEN Ltd. Manchester, United Kingdom). Briefly, control and decellularised dental pulp tissues (n = 4 per group) 
were digested using a Proteinase K solution. Samples were loaded onto spin columns and washed to remove pro-
tein and other contaminates. The DNA was eluted into DNase- and RNase-Free Eppendorf tubes and quantified 
using a NanoDrop Spectrophotometer at 260 nm (ND-2000C, Thermo Fisher Scientific).
Scanning electron microscopy. Control and decellularised pulp tissues (n = 4 per group) were fixed in 
2.5% (v/v) glutaraldehyde, washed in distilled water and dehydrated using ascending ethanol concentrations. 
Specimens were treated with 50% and 100% (v/v) hexamethyldisilazane solution and left to evaporate overnight. 
Specimens were then mounted on aluminium stubs, coated with gold in sputter coating unit and visualised 
under conventional high vacuum scanning electron microscope (SEM; Hitachi S-3400 N, High-Technologies, 
Ltd.) to evaluate tissue surface topography. All images were captured digitally.
Cell culture. L-929 murine fibroblasts (Health Protection Agency) were cultured in Dulbecco’s modified 
Eagle’s medium (DMEM, D6546) containing 10% (v/v) foetal calf serum (DE14-802), 100  U/mL penicillin, 
100 µg/mL streptomycin (P4333), and 2 mM L-glutamine (G7513, Lonza) at 37 °C in 5% (v/v)  CO2 in air; the 
medium was exchanged twice a week until the cells reached 80% confluency.
Human dental pulp stem cells (DPSCs) were obtained from Skeletal Research Tissue Bank, School of Den-
tistry, University of Leeds, following ethical approval (as mentioned above). DPSCs (passage 5) were cultured in 
alpha-modified Eagle’s medium (BE12-169F, Lonza) containing 10% (v/v) foetal calf serum, 100 U/mL penicillin, 
100 mg/mL streptomycin, and 2 mM L-glutamine at 37 °C in 5% (v/v)  CO2 in air; the medium was exchanged 
twice a week until the cells reached 80% confluency.
Contact cytotoxicity assay. Contact cytotoxicity assay was performed in a similar manner to previous 
 studies13,25. Samples of decellularised dental pulps (n = 4 per group) were attached to the centre of 6-well tissue 
culture plates using collagen type I (A10483-01, Gibco, Thermo Fisher Scientific). Cyanoacrylate glue (Z105902-
1EA) or collagen type I in triplicate wells served as positive and negative controls, respectively. L-929 cells were 
seeded into each well at a density that would allow confluency after 48 h in cell standard culture medium. Plates 
were incubated at 37 °C in 5% (v/v)  CO2 in air for 48 h. Following incubation, the culture medium was carefully 
aspirated before the wells were washed with PBS (pH 7.4) containing calcium and magnesium and fixed with 
10% (v/v) neutral buffered formalin for 10 min. The wells were then stained with Giemsa solution (Merck R66 
formulation, 352603R, VWR International, Ltd. Lutterworth, United Kingdom) for 5 min. The wells were rinsed 
with distilled water until clear and air dried. Changes in cell morphology and confluency were analysed using an 
inverted microscope under bright field illumination (Cell^B software) with all images captured digitally.
Extract cytotoxicity assay. Segments of decellularised dental pulps (n = 8) were finely minced and left 
to incubate in DMEM (1 mL/mg) for 72 h at 37 °C with agitation. Following incubation, the mixture was cen-
trifuged at 500  g for 15  min and the supernatant was collected. L-929 cells were seeded onto 96-well plates 
(Optiplate white plates; PerkinElmer Ltd. Beaconsfield, United Kingdom) at a density that would allow conflu-
ency after 24 h in standard culture medium. Plates were incubated at 37 °C in 5% (v/v)  CO2 in air. Following 
incubation, the culture medium was removed and replenished with 100 µL of fresh culture medium. For the 
study wells, 100 µL of decellularised extracts was added and further incubated for 24 h. 40% (v/v) dimethyl sul-
foxide (DMSO, D8418) or DMEM in triplicate wells served as positive and negative controls, respectively. The 
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cell viability (relative cellular Adenosine TriPhosphate [ATP] content) was then determined using the ATPlite 
Luminescence assay (6016941, PerkinElmer Ltd.) following manufacturer’s instructions.
Recellularisation of the decellularised pulp tissue. The decellularised rat dental pulp tissues were 
recellularised with human DPSCs. Decellularised tissues (n = 8) were individually placed in a sterile 200  µL 
capacity Eppendorf tube supplemented with 180 µL of a diluted cell suspension containing 1 × 104 cells. The 
Eppendorf tubes were sealed with OPSITE FLEXIGRID membrane (4628, Smith & Nephew, Watford, United 
Kingdom), placed within an in-house rotator apparatus (10 rpm) and incubated at 37 °C in 5% (v/v)  CO2 in air 
for 24 h. The scaffolds were transferred into a 12-well culture plates, topped up with 2 mL of fresh cell culture 
medium. The culture medium was changed twice a week throughout the duration of the experiment (7 and 
14 days).
Determination of viability of human DPSCs cultured on decellularised pulp tissue. Follow-
ing recellularisation, the ability of the decellularised scaffolds to support cell viability was analysed, at each 
time point, using a commercial LIVE/DEAD staining kit following the manufacturer’s instructions (Invitrogen 
L3224, Thermo Fisher Scientific). Stained scaffolds were then viewed under confocal Leica microscope (SP2 
PLUS; Leica Microsystems, Milton Keynes, UK).
Histological and immunohistochemistry assessment of human DPSCs cultured on decellular-
ised pulp tissue. Following recellularisation, the ability of the decellularised scaffolds to support stem cell 
attachment, growth and differentiation were analysed using H&E and immunohistochemical staining methods 
(n = 4, each time point). Standard histology and immunohistochemical methods were performed as previously 
described above. Primary antibodies against odontoblastic markers included mouse monoclonal dentine matrix 
protein-1 (DMP-1, 73633, 1:100, Santa Cruz Biotechnology, Inc., Heidelberg, Germany), dentine sialophos-
poprotein (DSPP, 73632, 1:1000, Santa Cruz Biotechnology, Inc.), and rabbit polyclonal alkaline phosphatase 
(ALP, GTX100817, 1:1000, BD BioScience, Oxford, United Kingdom). Structural components included mouse 
monoclonal alpha-smooth muscle actin (α-SMA, ab7817, 1:500, Abcam), nestin (MAB1259, 1:5000, R&D Sys-
tems, Abingdon, United Kingdom), and vimentin (M0725, 1:10000, Dako). Growth factors including rabbit 
polyclonal vascular endothelial growth factor (VEGF-A, ab46154, 1:200, Abcam), and rabbit monoclonal vas-
cular endothelial growth factor receptor-2 (VEGFR-2, 2479, 1:25, Cell Signaling Technology, Inc. Leiden, The 
Netherlands) antibodies were also assessed.
Statistical analysis. Quantitative data was analysed using either an independent Student’s t-tests or one-
way analysis of variance (ANOVA) depending on the number of groups. All experiments were performed in 
triplicates. The statistical analysis was performed using Prism 6 (GraphPad Software, California, USA), p-val-
ues < 0.05 were considered significant.
Results
Decellularisation assessment. Decellularisation efficiency of rat dental pulp tissues was performed using 
both qualitative and quantitative assessment methods. Histology analysis using H&E and DAPI staining revealed 
a high density of cells within control (native) dental pulps and absence of cells in decellularised samples (Fig. 1a). 
Immunolabelling with major histocompatibility complex class II antibodies also revealed a positive immunore-
activity in the control pulp tissues, this positive staining was associated with specific cells scattered throughout 
the ECM (Fig. 1a). In contrast, a negative immunoreactivity was detected in the decellularised samples (Fig. 1a). 
No brown staining was seen in isotype stained sections (images not provided).
Quantitative analysis using total DNA from both control and decellularised pulp tissues was extracted and 
quantified. The mean DNA content in the decellularised tissues was 23.00 ± 1.430 ng DNA per mg of dry tissue, 
in comparison to the 1765 ± 20.66 ng DNA per mg of dry control tissues. This reduction of over 98% was found 
to be significantly different when compared to the control tissue (Fig. 1b).
Collagen structure assessment. Assessment of the collagen structure of rat dental pulp tissues was per-
formed using both histology and immunohistochemistry analysis. Histological characterisation of picrosirius 
red stained control tissues viewed under both bright field and polarised light microscopy revealed a collagen 
matrix mainly composed of thin filaments and fibrils that were weakly birefringent to light (Fig. 2). Following 
decellularisation, the collagen fibre network was overall well preserved throughout the entire matrix (Fig. 2). 
Antibody labelling against collagen type I and type III was additionally performed (Fig. 2). In control tissues, 
a weak positive immunoreactivity to collagen type I and III antigens was observed. These thin fibres and fibrils 
were distributed throughout the matrix, mainly concentrated around and along the vasculature. Following 
decellularisation, a positive but less intense staining pattern was seen (Fig. 2). No brown staining was seen in 
isotype stained sections (images not provided).
Non-collagenous structures assessment. Assessment of the non-collagenous ECM components of 
rat dental pulp tissues was performed using histology and immunohistochemistry analysis. Histological char-
acterisation of alcian blue stained control tissues revealed a glycosaminoglycan rich tissue (Fig. 3). Following 
decellularisation, preservation of glycosaminoglycan molecules was evident with no visible differences between 
the control and the decellularised tissues (Fig. 3). Antibody labelling against structural proteins and α-gal was 
performed (Fig. 3). In control tissues, fibronectin and laminin appeared as a fibrous plexus mainly concentrated 
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around the vasculature. Following decellularisation, a positive but noticeably weaker staining pattern against 
fibronectin was observed. Although laminin staining was less intense in comparison to the control tissues, the 
distribution was comparable to control tissues, it was found to be present throughout the entire ECM mainly 
concentrated around the basement membrane of vasculature structures. No evidence of α-gal was observed 
within the decellularised ECM (Fig. 3). No brown staining was seen in isotype stained sections (images not 
provided).
Scanning electron microscopy. Structural assessment of rat dental pulp analysed under SEM revealed a 
complex irregular fibre mesh structure related to the control tissues (Fig. 4a). Following decellularisation, preser-
vation of complex fibre mesh denuded of some components, mainly cell and cell fragments was evident (Fig. 4b).
Contact cytotoxicity assay. Microscopic analysis of the cell culture plates showed L-929 cell growth up 
to and in contact with the samples of decellularised dental pulp (Fig. 5a). No obvious morphological change nor 
Figure 1.  Decellularisation assessment. (a) Representative images of histological and immuolabelled rat 
pulp tissues. H&E and DAPI staining methods show highly cellular control tissues (nuclei stained blue) in 
comparison to no nuclear material staining of decellularised tissues. A positive immunoreactivity against 
major histocompatibility complex class II antigens were seen in control tissues, in contrast a negative 
immunoreactivity in decellularised tissues. (b) Bar graph results of DNA quantification assay determined by 
Nanodrop spectrometer. Y-axis; DNA content ng per mg of dry tissue. Data represent mean values (n = 4) ± 95% 
confidence intervals. The mean DNA measurements in the decellularised tissues contained 23.00 ± 1.43 ng/
mg in comparison to 1756 ± 20.66 ng/mg in the control tissues (t test, ****p < 0.0001). DAPI 4′,6-diamidino-2-
phenylindole. Scale bars are at 50 µm.
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cell lysis were noted. Collagen gel alone (negative control) showed no signs of cytotoxicity, while cyanoacrylate 
glue (positive control) resulted in cell lysis.
Extract cytotoxicity assay. There was no significant reduction in the cellular ATP levels of the L-929 
cells following incubation with soluble extracts of decellularised dental pulps compared with that of the DMEM 
(negative control) (ANOVA, p > 0.05; Fig. 5b). In contrast, DMSO (positive control) caused an almost total loss 
of ATP and were significantly lower than any other sample group (ANOVA, p < 0.0001; Fig. 5b).
Determination of viability of human DPSCs cultured on decellularised pulp tissue. The viabil-
ity of DPSCs following recellularisation on the decellularised scaffolds was assessed using standard LIVE/DEAD 
staining kit. Following 7 and 14 days culture, Z-stack constructed confocal laser images clearly demonstrated 
Figure 2.  Collagen structure assessment. Representative images of rat dental pulp tissues stained with 
picrosirius red, labelled with collagen type I and III antibodies. Control tissues reveal a porous collagen 
matrix, mainly composed of immature collagen fibres (stained green under the polarised light), and a weak 
positive immunoreactivity to collagen type I and III antigens. Following decellularisation, preservation of an 
acellular porous collagen matrix and a positive, but reduced, staining pattern of collagen type I and III fibres in 
comparison to the control tissues was evident. Scale bars are at 100 and 50 µm.
Figure 3.  Non-collagenous structures assessment. Representative images of rat dental pulp tissues stained 
with alcian blue, labelled with fibronectin, laminin and α-gal antibodies. Control tissues reveal a rich 
glycosaminoglycans rich matrix and a positive immunoreactivity to fibronectin, laminin proteins and α-gal. 
Following decellularisation, preservation of glycosaminoglycans, fibronectin and laminin proteins with negative 
α-gal staining was evident. α-gal alpha-1,3 galactose. Scale bars are at 50 µm.
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viable cells (stained green with Calcein-AM), of elongated morphology, repopulating the decellularized scaffolds 
with limited appearance of dead cells (stained red with ethidium homodimer) (Fig. 6).
Histological assessment of human DPSCs cultured on decellularised pulp tissue. Serial sec-
tions of the recellularised scaffolds were assessed with H&E staining to determine the ability of DPSCs to 
attach, migrate and differentiate within the decellularised scaffolds. Following 7 and 14 days culture, the DPSCs 
appeared elongated with a spindle-shaped morphology attached to the outer scaffold surface and between the 
collagen fibers. As time elapsed, there was an apparent change in the scaffold shape from a longitudinal (day 7) 
to a contracted circular shape (day 14; Fig. 6).
Immunohistochemistry assessment of human DPSCs cultured on decellularised pulp tis-
sue. Antibody labelling was performed to assess the ability of the seeded DPSCs to express cytoskeleton 
Figure 4.  Scanning electron microscopy surface assessment. (a) Control rat dental pulp tissues reveal a 
complex irregular fibre mesh structure. (b) Decellularised tissue show structural preservation. Scale bar at 5 µm.
Figure 5.  Cytotoxicity analysis of decellularised rat pulp tissue. (a) Microscopic analysis of contact cytotoxicity 
assay cultured with L-929 cells and stained with Giemsa stain. Decellularised tissues resulted in no obvious 
cytotoxicity with cell growth in contact with the pulp tissue. Collagen gel (negative control) resulted in no 
cytotoxicity. Cyanoacrylate glue (positive control) resulted in marked cytotoxicity. (b) Bar graph results of 
extract cytotoxicity assay measuring the relative cellular ATP content of L-929 cells. Y-axis relative cellular 
ATP measurements. Data represent mean values (n = 8) ± 95% confidence intervals. Data analysis revealed no 
significant difference between decellularised extracts and DMEM (negative control) and statistical significance 
in comparison with DMSO (positive control) (ANOVA, ****p < 0.0001). ATP adenosine-5-triphosphate, DMEM 
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components, growth factors and odontoblastic markers. Odontoblastic markers, DMP-1 and ALP, were weakly 
stained at day 7 with an increase in staining intensity following longer culture duration (day 14; Fig. 7). In con-
trast, DSPP was strongly positive following 7 and 14 days culture (Fig. 7).
The seeded DPSCs were stained dark brown against vimentin, nestin, VEGF-A, and VEGFR-2 antigens 
indicating strong positive cellular immunoreactivity. These antigen positive cells were scattered throughout the 
Figure 6.  DPSCs viability and attachment following recellularisation of the decellularised pulp scaffold. (a) 
Confocal laser microscope images of cell viability assay following 7 and 14 day culture clearly show a well-
populated scaffold with viable cells (stained green) and scarce dead cells (stained red). Scale bars are at 300 µm. 
(b) Representative images of H&E staining revealed DPSCs attached and migrated within the decellularised 
scaffold. As culture time increased, the seeded scaffold contracted from longitudinal shape (day 7) to a circular 
shape (day 14). DPSCs dental pulp stem cells. Scale bars are at 100 and 50 µm.
Figure 7.  Odontoblastic markers following recellularisation of the decellularised pulp scaffold. Representative 
images of immunohistochemical labelled tissues showing a positive immunoreactivity against DSPP positive 
cells at 7 and 14 days culture. DMP-1 and ALP, were weakly stained at day 7 with an increase in staining 
intensity at day 14. DSPP dentine sialophospoprotein, DMP-1 dentine matrix protein 1, ALP alkaline 
phosphatase. Scale bars are at 20 µm.
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scaffold at day 7 and 14 culture (Fig. 8). However, α-SMA was weakly stained at day 7 with an increase in stain-
ing intensity following 14 days culture (Fig. 8). No brown staining was seen in isotype stained sections (images 
not provided).
Discussion
Scaffold development for use in regenerative (reparative) endodontics is currently the subject of intense research 
in an attempt to improve the clinical outcomes and prognosis of these vulnerable teeth. The ECM is regarded 
as a vital component of all tissues and, possibly, the ideal scaffold for tissue  engineering14. Therefore, develop-
ing a biocompatible decellularised ECM scaffold is deemed likely to allow the ideal environment for stem cell 
repopulation and differentiation.
The decellularisation protocol performed in this work, involved cell membrane lysis in a hypotonic Tris buffer, 
solubilisation of cytoplasmic and nuclear components using a single detergent cycle of 0.03% SDS, followed by 
removal of cellular material with a nuclease treatment.
Rat dental pulp tissues were used in this work due to histological structural similarities to human pulp 
 tissue23,24. The use of laboratory rats is also well known as inevitable part of translational biomedical  research26, 
and considered an alternative tissue source due to the limited availability of human pulp tissues for experimental 
studies.
Collagen fibres are known as the most abundant fibrous component of the dental  pulp27, and largely contribute 
towards the development and maintenance of the pulp  matrix28. Analysis of the dried pulp tissue obtained from 
rat incisors revealed a low collagen content of around 3.5%23, with collagen type I and III representing the main 
bulk of  collagen23,29,30. This low collagen content was in line in with our results showing immature collagen fibres 
stained green as viewed under the polarised light and a weak positive immunoreactivity to collagen type I and 
III antigens within the control tissues. Surface topography assessment of control rat dental pulp viewed under 
SEM revealed a complex irregular fibre mesh structure. Following decellularisation, preservation of structural 
collagen was evident with various qualitative methods utilized.
Therefore, in this work decellularised rat dental pulp tissues resulted in a biocompatible acellular scaffold 
with preservation of the connective tissue architecture, retained vascular channels and ECM proteins similar to 
those obtained following decellularisation of the human dental pulp  tissue6.
Xenogenic hyperacute rejection is reported to be mediated by complement activation of antibodies against 
α-gal  epitope31,32. Therefore, complete removal of α-gal epitope from the xenogenic tissue is essential. The results 
of this work showed no evidence of α-gal expression following immunohistochemical assessment of decellular-
ised rat pulp tissues. These results are in line with those reported following decellularisation of porcine medial 
 meniscus33, porcine bone  cartilage34, and porcine pulmonary  valve25, using comparable decellularisation proto-
cols. A negative immune-reactivity against major histocompatibility complex class II molecules was also evident 
following decellularisation. These specific class of molecules are expressed by immune cells such as monocytes, 
macrophages and dendritic cells and serve as initial defence  cells35,36.
Following recellularisation with DPSCs, the produced ECM scaffolds were able to support stem cell viability, 
attachment and migration in vitro. As time elapsed, a decrease in the overall size of the seeded scaffold was 
apparent, changing from original tubular shape observed at day 7 to a circular shape at day 14. Contraction of 
cell-seeded scaffolds has been reported in the literature following recellularisation of polyglycolic acid matrices 
with human fibroblastic  cells37, and collagen-glycosaminoglycan matrices seeded with  DPSCs38. This matrix 
contraction was thought to be linked to the expression of α-SMA positive  cells38. The expression of α-SMA by 
DPSCs cultured on rat decellularised scaffolds, demonstrated in this study, is likely to have contributed to the 
contraction of the scaffolds. Further work is needed to assess this hypothesis in addition to the effects of such 
contraction on cell penetration, survival and differentiation.
Figure 8.  Gene expression following recellularisation of the decellularised pulp scaffold. Representative 
images of immunohistochemical labelled tissues revealed a positive immunoreactivity against nestin, vimentin, 
VEGF-A, and VEGFR-2 positive cells at 7 and 14 days culture. α-SMA was weakly stained at day 7 with an 
increase in staining intensity at day 14. α-SMA alpha smooth muscle actin, VEGF-A vascular endothelial growth 
factor-A, VEGFR-2 vascular endothelial growth factor receptor 2. Scale bars are at 20 µm.
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In the present study, immunohistochemical labelling of recellularised rat scaffolds showed a positive expres-
sion against several genes and odontoblast markers. DPSCs seeded within the decellularised scaffolds expressed 
putative markers of odontoblastic differentiation including DSPP, DMP-1 and ALP following 14 days culture in 
standard medium conditions. These markers, although non-specific, have been recommended in identifying cell 
differentiation towards odontoblastic-like cell  lineage39,40. Previous in vivo studies assessing the odontoblastic 
differentiation of stem cells reported a positive expression to DSPP and DMP-1 following 21 days culture when 
Puramatrix was seeded with either DPSCs in tooth slice  model41, or stem cells from human exfoliated deciduous 
teeth in full length root  canals42. Furthermore, human recombinant collagen scaffolds seeded with stem cells from 
human exfoliated deciduous resulted in a positive expression for DSPP and DMP-1 following 14 and 28 days 
culture,  respectively42. Interestingly, odontoblastic differentiation of stem cells was not possible in both seeded 
scaffolds without the surrounding dentine  structure41,42. Song et al. (2017) also reported positive expression of 
odontoblastic markers following 14 days cell culture utilizing a decellularised pulp tooth slice  model20. In con-
trast, the present study revealed stem cell differentiation solely within the decellularised scaffold. Indeed, tooth 
specific environmental cues have a significant impact on the differentiation ability of stem cell into odontoblastic 
 lineages43–45. Hence, it could be hypothesised, that placement of the decellularised scaffold in direct contact with 
the surrounding tooth structure enhances the tissue engineering process, with new tissue formation in close 
resemblance to the control tissue.
Successful engineering of a pulp-dentine complex also depends on angiogenesis and neurogenesis. Nestin, 
an intermediate filament protein, is classified as a neural progenitor marker and has been found to be expressed 
in newly differentiated and functioning odontoblast  cells46,47. Vimentin, a major intermediate filament protein, 
has also been linked to neurogenesis and expressed by neuronal precursor  cells48. Although vimentin is not 
considered as a pulp tissue specific protein, it has been suggested as a dental pulp quality standard protein for 
characterisation of pulp  regeneration49. Indeed exposure of DPSCs to the correct environmental cues is crucial 
for their ultimate differentiation into active  neurons50. Angiogenesis, on the other hand, aids in the transport 
of oxygen, nutrients and in attracting prevascular stem cells to the regenerated site, thereby preventing tissue 
 necrosis51,52. Notably, several studies highlighted the ability of DPSCs in inducing angiogenesis and the expression 
of proangiogenic factors including VEGF-A and VEGFR-253,54. The immunolabelling results of this study showed 
positive cellular expression against nestin, vimentin, VEGF-A, and VEGFR-2 antigens following recellularisation 
indicating, a possibility, of active neurogenesis and angiogenesis.
In conclusion, results of this work indicate successful decellularisation of rat dental pulp tissues utilising a 
single low concentration detergent based decellularisation protocol. The resulting biocompatible scaffold was 
able to support dental pulp stem cell repopulation over a 14 day period. The recellularised scaffold also showed 
a positive cellular expression against odontoblastic markers, cytoskeleton proteins, and growth factors.
Additional scaffold testing utilizing ex vivo culture models; tooth  slice55 and ectopic root transplantation 
 models56,57 in order to assess scaffolds ability to regenerate within the surrounding environment is of importance 
for future clinical  translation58. Following animal testing, all work will be duplicated on human tissue for future 
clinical trials.
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